Patheon Goodwill and Intangible Assets 2015-2017 | PTHN

Patheon goodwill and intangible assets from 2015 to 2017. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Patheon Goodwill and Intangible Assets 2015-2017 | PTHN

Patheon goodwill and intangible assets from 2015 to 2017. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$72B
Zoetis (ZTS)$69.3B
Takeda Pharmaceutical (TAK)$47.7B
Daiichi Sankyo, - (DSNKY)$45.3B
BeOne Medicines - (ONC)$33.5B
Sandoz Group AG (SDZNY)$27.7B
Summit Therapeutics (SMMT)$17.6B
Merck (MKKGY)$16.4B
Shionogi (SGIOY)$14.6B
Neurocrine Biosciences (NBIX)$13.8B
United Therapeutics (UTHR)$13.7B
IPSEN (IPSEY)$11.4B
Orion OYJ (ORINY)$11.2B
Madrigal Pharmaceuticals (MDGL)$9.7B
Eisai (ESAIY)$8.9B
Corcept Therapeutics (CORT)$7.3B
Stevanato Group S.p.A (STVN)$7B
Grifols, S.A (GRFS)$6.9B
Ionis Pharmaceuticals (IONS)$6.8B
Ono Pharmaceutical (OPHLF)$5.7B
Hikma Pharmaceuticals Plc (HKMPF)$5.4B
Soleno Therapeutics (SLNO)$3.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)$3B
Crinetics Pharmaceuticals (CRNX)$2.9B
NewAmsterdam Pharma (NAMS)$2.7B
Hypermarcas (HYPMY)$2.7B
Procaps Group, S.A (PROCF)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.2B
Ocular Therapeutix (OCUL)$2.1B